ArticleCancer cell international2014

An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study.

Lisa Repsold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.